Circassia Pharmaceuticals Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.8M
Doctors Paid
15,176
Transactions
32,636
2020 Total
$18,906
Payment Breakdown by Category
Research$1.3M (46.7%)
Food & Beverage$613,489 (21.8%)
Consulting$74,564 (2.6%)
Travel$27,615 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 363 | 46.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $777,546 | 545 | 27.6% |
| Food and Beverage | $613,489 | 31,557 | 21.8% |
| Consulting Fee | $74,564 | 29 | 2.6% |
| Travel and Lodging | $27,615 | 104 | 1.0% |
| Honoraria | $6,500 | 4 | 0.2% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,500 | 1 | 0.1% |
| Education | $963.58 | 33 | 0.0% |
Payments by Type
General
$1.5M
32,273 transactions
Research
$1.3M
363 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis | $981,568 | 70 | 234 |
| A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode | $153,200 | 6 | 10 |
| An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment | $110,545 | 27 | 100 |
| Exhaled nitric oxide in COPDGene | $31,500 | 0 | 2 |
| The use of fractional exhaled nitric oxide in the management of asthma in the primary care setting | $12,000 | 0 | 1 |
| Exhaled nitric oxide FeNO as a predictor for anesthesia related respiratory complications in children a pilot study | $7,700 | 0 | 1 |
| A Combined Phase 2b3, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Centre Study to Assess the Efficacy and Safety of Grass-SPIRE in Subjects With Grass Pollen-Induced Allergic Rhinitis, With or Without Conjunctivitis | $5,078 | 1 | 1 |
| Circassia HDM-SPIRE liquid | $4,881 | 1 | 10 |
| Patient empowered strategy to reduce asthma morbidity to highly impacted populations PREPARE | $3,250 | 0 | 1 |
| A Clinical Investigation Determining the Discriminative Ability of the NIOX VERO NASAL to Differentiate Subjects With Primary Ciliary Dyskinesia From Healthy Controls | $3,000 | 1 | 1 |
| Assessment of user-device interactions with the NIOX VERO Nasal Application that can be used with NIOX PanelNasal Program | $3,000 | 1 | 1 |
| 304405-9 | $20.00 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Neal Jain, Md, MD | Allergy & Immunology | Gilbert, AZ | $101,494 | $0 |
| Lawrence Sher, M.d, M.D | Allergy | Rolling Hills Estates, CA | $97,979 | $0 |
| Dr. Gordon Raphael, M.d, M.D | Allergy & Immunology | Bethesda, MD | $72,863 | $0 |
| Dr. Mark Pamer, D.o, D.O | Critical Care Medicine | Port Saint Lucie, FL | $46,447 | $0 |
| Anthony Montanaro, Md, MD | Allergy & Immunology | Portland, OR | $42,219 | $0 |
| Elliot Israel, Md, MD | Critical Care Medicine | Brookline, MA | $37,700 | $0 |
| Margaret Leigh, Md, MD | Pediatric Pulmonology | Chapel Hill, NC | $34,651 | $0 |
| Alexander Greiner, M.d, M.D | Allergy & Immunology | San Diego, CA | $33,110 | $0 |
| Dr. Robert Call, M.d, M.D | Allergy | Richmond, VA | $32,638 | $0 |
| David Bernstein, M.d, M.D | Pediatric Infectious Diseases | Cincinnati, OH | $32,013 | $0 |
| Dr. Don Bukstein, Md, MD | Allergy & Immunology | Fitchburg, WI | $31,883 | $0 |
| Mark Moss, Md, MD | Pediatric Allergy/Immunology | Madison, WI | $30,674 | $0 |
| Unknown Provider | — | — | $30,475 | $0 |
| Randall Brown, Md Mph, MD MPH | Pediatric Pulmonology | Atlanta, GA | $29,742 | $0 |
| Stephanie Davis, Md, MD | Pediatric Pulmonology | Chapel Hill, NC | $28,600 | $0 |
| Robert Anolik, Md, MD | Allergy & Immunology | Blue Bell, PA | $27,858 | $0 |
| James Deangelo, D.o, D.O | Allergy | Pittsburgh, PA | $27,759 | $0 |
| Bradley Chipps, M.d, M.D | Allergy | Sacramento, CA | $27,350 | $0 |
| Dr. Weily Soong, M.d, M.D | Specialist | Birmingham, AL | $26,387 | $0 |
| Dr. William Lumry, M.d, M.D | Specialist | Dallas, TX | $24,458 | $0 |
| Unknown Provider | — | — | $23,781 | $0 |
| Bruce Prenner, Md, MD | Allergy & Immunology | San Diego, CA | $23,417 | $0 |
| Jonathan Corren, Md, MD | Clinical & Laboratory Immunology | Los Angeles, CA | $23,283 | $0 |
| Unknown Provider | — | — | $22,996 | $0 |
| Dr. Iftikhar Hussain, Md, MD | Allergy & Immunology | Tulsa, OK | $22,560 | $0 |
Ad
Top Products
- NIOX VERO DEVICE $949,005
- TUDORZA PRESSAIR $407,322
Associated Products (5)
- NIOX VERO DEVICE $949,005
- TUDORZA PRESSAIR $433,782
- NIOX VERO $183,888
- DUAKLIR PRESSAIR $34,727
- DUAKLIR $24,828
Payment Categories
- Food & Beverage $613,489
- Consulting $74,564
- Travel & Lodging $27,615
- Research $1.3M
About Circassia Pharmaceuticals Inc
Circassia Pharmaceuticals Inc has made $2.8M in payments to 15,176 healthcare providers, recorded across 32,636 transactions in the CMS Open Payments database. In 2020, the company paid $18,906. The top product by payment volume is NIOX VERO DEVICE ($949,005).
Payments were distributed across 123 medical specialties. The top specialty by payment amount is Allergy & Immunology ($924,948 to 926 doctors).
Payment categories include: Food & Beverage ($613,489), Consulting ($74,564), Research ($1.3M), Travel & Lodging ($27,615).
Circassia Pharmaceuticals Inc is associated with 5 products in the CMS Open Payments database, including NIOX VERO DEVICE, TUDORZA PRESSAIR, and NIOX VERO.